Finance

Lists
Why is TNYA down ၆.၇၈%?
Dive Deeper
TNYA:NASDAQ
Tenaya Therapeutics Inc
၀.၃၈ US$
-၆.၇၈%
(-၀.၀၂၈) 1D
၀.၃၈ US$
+၁.၁၃% (+၀.၀၀၄၃)
After hours
Closed: အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNYA...
Open
၀.၄၁ US$
High
၀.၄၂ US$
Low
၀.၃၇ US$
Mkt. cap
၈.၅၀ ကုဋေ
Avg. vol.
၃.၄၂ သန်း
Volume
၆.၈၄ သန်း
52-wk high
၂.၀၂ US$
52-wk low
၀.၃၆ US$
EPS
-၀.၅၃ US$
Beta
၂.၈၇
Shares outstanding
၂၂.၄၂ ကုဋေ
No. of employees
၇၀
Open
၀.၄၁ US$
High
၀.၄၂ US$
Low
၀.၃၇ US$
Mkt. cap
၈.၅၀ ကုဋေ
Avg. vol.
၃.၄၂ သန်း
Volume
၆.၈၄ သန်း
52-wk high
၂.၀၂ US$
52-wk low
၀.၃၆ US$
EPS
-၀.၅၃ US$
Beta
၂.၈၇
Shares outstanding
၂၂.၄၂ ကုဋေ
No. of employees
၇၀
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
Sandisk Is Dominating the S&P 500 in 2026. Can It Repeat in 2027?
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၄၄ မိနစ်
Turn Therapeutics (NASDAQ:TTRX) Cut to "Sell" at Wall Street Zen
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၅၄ မိနစ်
Amgen (NASDAQ:AMGN) Upgraded at Wall Street Zen
MarketWatch
MarketWatch
·
ပြီးခဲ့သည့် ၁ ရက်
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
About Tenaya Therapeutics Inc
CEO-
Employees၇၀
Founded၂၀၁၆
HeadquartersSouth San Francisco, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to TNYA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TNYA in the last 3 months.
Highest
Current ၀.၃၈ US$
၄၀.၀၀ US$ (+၁၀,၄၀၆.၉၆%)
Average
၁၃.၀၀ US$ (+၃,၃၁၄.၇၆%)
Lowest
၃.၀၀ US$ (+၆၈၈.၀၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
၃.၀၀ US$
+၆၈၈%
10/05/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
၅.၀၀ US$
+၁,၂၁၃.၄%
08/06/2026
Cory Jubinville, PhD
LifeSci Capital
Buy
Maintained
၄.၀၀ US$
+၉၅၀.၇%
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
၄၀.၀၀ US$
+၁၀,၄၀၇%
08/06/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/06/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
07/29/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
၂.၀၀ US$
+၄၂၅.၃%
06/03/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
၈.၀၀ US$
+၂,၀၀၁.၄%
05/15/2026
Last report
၂၀၂၆ ဩ ၅
Fiscal period
Q2 2026
-၀.၀၉ US$ / -၀.၀၇ US$
-၃၅.၉၀%miss
Revenue / Est. (USD)
၁.၁၁ သန်း / ၁.၀၀ ကုဋေ
-၈၈.၉၀%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
၂.၂၅ သိန်း
၁.၁၁ သန်း
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၅၄ ကုဋေ
၁.၄၈ ကုဋေ
၁.၄၈ ကုဋေ
၁.၆၆ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅.၅၇ သန်း
၅.၉၈ သန်း
၅.၄၅ သန်း
၅.၄၁ သန်း
Operating expense
၂.၀၉ ကုဋေ
၂.၀၈ ကုဋေ
၂.၀၃ ကုဋေ
၂.၂၀ ကုဋေ
Total operating expenses
၂.၀၉ ကုဋေ
၂.၀၈ ကုဋေ
၂.၀၃ ကုဋေ
၂.၂၀ ကုဋေ
Operating income
-၂.၀၉ ကုဋေ
-၂.၀၈ ကုဋေ
-၂.၀၁ ကုဋေ
-၂.၀၉ ကုဋေ
Other non operating income
၃.၀၀ ထောင်
၂.၅၀ သောင်း
-
-၁.၃၇ သန်း
EBT including unusual items
-၂.၀၃ ကုဋေ
-၂.၀၂ ကုဋေ
-၁.၉၃ ကုဋေ
-၄.၃၄ ကုဋေ
EBT excluding unusual items
-၂.၀၃ ကုဋေ
-၂.၀၂ ကုဋေ
-၁.၉၃ ကုဋေ
-၂.၁၆ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၀၃ ကုဋေ
-၂.၀၂ ကုဋေ
-၁.၉၃ ကုဋေ
-၄.၃၄ ကုဋေ
Net profit margin
-
-
-၈,၅၆၅.၃၃%
-၃,၉၀၉.၂၈%
Earnings per share
-၀.၁၂
-၀.၁၂
-၀.၀၉
-၀.၀၉
Interest and investment income
၆.၅၈ သိန်း
၅.၇၅ သိန်း
၇.၉၃ သိန်း
၆.၉၇ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၆.၅၈ သိန်း
၅.၇၅ သိန်း
၇.၉၃ သိန်း
၆.၉၇ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၉၁ ကုဋေ
-၁.၈၉ ကုဋေ
-၁.၈၃ ကုဋေ
-၁.၉၂ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ